Alexandra Valenti, an associate in Goodwin’s Intellectual Property Litigation group, focuses her practice on patent matters, with an emphasis on biotechnology and pharmaceuticals. Ms. Valenti has represented clients in numerous patent infringement lawsuits nationwide, and has significant trial and appellate experience. Ms. Valenti is also an editor of the firm’s biosimilars blog, Big Molecule Watch, which provides resources and observations through Goodwin’s active watch of legal, business and regulatory developments related to biologics, biosimilars and the Biologics Price Competition and Innovation Act (BPCIA).





Ms. Valenti has experience representing companies in all stages of patent litigation, from pre-suit investigation through trial and appeal. Some of her recent engagements include:

  • Representing The Gillette Company in litigation filed against Dollar Shave Club, Inc. Gillette has asserted infringement of a patent directed to razor blade coatings.
  • Defending IBM as a third-party intervenor in patent infringement suits before the United States Court of Federal Claims, filed against the federal government, regarding computer systems for providing disaster warnings. 
  • Represented Actavis Laboratories FL, Inc. in a trial victory over Tris Pharma in federal court in Delaware,  paving the way for Actavis to launch a generic version of Quillivant XR® (methylphenidate hydrochloride), a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The Court found invalid five patents covering Quillivant®’s formulation and use, which would have protected the drug from generic competition for another 14 years.
  • Represented Teva Pharmaceuticals USA, Inc. in patent infringement litigation, including trial and appeal, filed by Genzyme Corp. regarding Teva’s application to market a generic version of Genzyme’s stem cell mobilizing agent, Mozobil® (plerixafor).
  • Represented Teva in a patent infringement action filed by Otsuka relating to Teva’s filing of abbreviated new drug applications for generic versions of Otsuka’s drug Abilify® (aripiprazole). Teva defeated a motion for a temporary restraining order, allowing Teva to launch its products. The case against Teva settled favorably before trial.
  • Represented Glenmark Pharmaceuticals in patent infringement litigation, including trial and appeal to the Federal Circuit, filed by Intendis GmbH and Bayer Healthcare Pharmaceuticals Inc. based on Glenmark’s filing of an abbreviated new application seeking approval for a generic version of Bayer’s topical rosacea treatment, Finacea® (azelaic acid).
  • Represented Teva in a successful patent infringement appeal concerning its generic version of the brand drug Lovenox® (enoxaparin sodium). In its decision, the Federal Circuit affirmed summary judgment of noninfringement because Teva does not import a product “made by” a patented process, allowing continued sale of its generic product.

Pro Bono

Ms. Valenti has an active pro bono practice. In 2017, she led a team that submitted an amicus brief to the Supreme Court of Ohio on behalf of the Joyful Heart Foundation, an organization committed to healing, education and advocacy on behalf of victims of sexual assault. The Court agreed with the positions taken by Joyful Heart in its brief, and overturned a decision dismissing rape and kidnapping charges against an alleged serial rapist based on pre-indictment delay.

In 2016, Ms. Valenti gained significant trial experience during a six-month secondment with the Kings County (Brooklyn) District Attorney’s Office, where she served as an assistant district attorney. During this time, she prosecuted numerous felony cases on behalf of the state of New York, including a bench trial, a jury trial and several hearings. In other work with the Kings County District Attorney’s Office, Ms. Valenti successfully briefed and argued an appeal before the New York Supreme Court Appellate Division, Second Judicial Department, ensuring a criminal defendant convicted of robbery remained in prison.

Ms. Valenti also represented Merkos L’Inyonei Chinuch, the educational arm of the Chabad-Lubavitch movement of Orthodox Judaism, in a copyright infringement case filed in federal court in Brooklyn. Ms. Valenti co-authored a successful motion for summary judgment, securing judgment that Merkos did not infringe copyrights on religious texts.  

Professional Activities

Ms. Valenti is a member of the Hon. William C. Conner Inn of Court and the New York Intellectual Property Law Association (NYIPLA). She is also a member of the Manhattan Institute’s Young Leaders Circle.

Professional Experience

Prior to joining Goodwin, Ms. Valenti was a legislative aide for Rep. Peter T. King (NY) in the U.S. House of Representatives.


While attending law school, Ms. Valenti was selected as a member of Georgetown University Law Center’s Moot Court Team. She was a semifinalist in the 2011 NYU Immigration Law Competition and was awarded best brief. Also during law school, Ms. Valenti was the symposium editor of the Georgetown Journal of Law and Public Policy and earned CALI awards in Evidence and Church-State Law.

In The News









J.D., 2012
Georgetown University Law Center
(cum laude)
B.A., Physics and Political Science, 2007
The George Washington University
(magna cum laude)



New York


U.S. District Court for the Southern District of New York
U.S. District Court for the Eastern District of New York
U.S. Court of Appeals for the Federal Circuit
Get In Touch
German Translation
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.

Unsere Kunden verlassen sich auf unsere erstklassige Beratung, vor allem im Hinblick auf komplexe Transaktionen und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Branchen, verwenden wir einen kooperativen und interdisziplinären Ansatz, um Fragen unserer Kunden auch in extremen Spezialsituationen einer Lösung zuzuführen. Sie wollen mehr erfahren? Kontaktieren Sie uns gerne.

Nos équipes interviennent aux côtés de nos clients, industriels, fonds d’investissement, startups, institutions financières et dirigeants, dans le cadre de transactions et de contentieux complexes, et apportent des conseils de tout premier plan dans les secteurs financiers, des Sciences de la Vie, du Private Equity, de l’immobilier et des technologies. Nous traitons les dossiers juridiques de manière intègre, ingénieuse, souple et audacieuse pour répondre efficacement aux enjeux propres à chacun de nos clients, quels que soient la taille de l’opération et le secteur d’activité. Pour en savoir plus, contactez-nous.


Search Other Lawyers
Recherche par Pratique